News | December 15, 2011

Diablo Valley Oncology Performs its First Breast Intraoperative Radiation Procedure

December 15, 2011 – Diablo Valley Oncology, an oncology practice in the San Francisco East Bay, recently administered its first breast intraoperative radiation treatment (IORT) using the Xoft Axxent eBx electronic brachytherapy system at Aspen Surgical in Walnut Creek.

"We are excited to be the first practice to offer this type of treatment to patients in the East Bay," said Sachin Kamath, M.D., medical director of radiation at Diablo Valley Oncology. "Offering IORT allows more breast cancer patients access to potentially lifesaving radiation therapy that is safe, highly effective, and less time consuming."

IORT enables doctors to administer a high dose of radiation to the tumor bed during the lumpectomy, which reduces or eliminates the need for follow-up radiation treatments and also minimizes radiation exposure to healthy tissue and organs. The current standard of care for early stage breast cancer consists of lumpectomy, followed by a six-week course of daily whole breast radiation therapy or a five-day regimen with balloon brachytherapy (10 treatments). Studies have shown that with breast IORT, a single dose of intraoperative radiation may be as effective in treating the tumor as 10-20 daily radiation doses.

"Radiation therapy is a critical element of breast cancer treatment, however historically it has required several weeks of daily treatments, which can pose a financial and logistical challenge for some patients," said Kamath. "The Xoft eBx System gives us the ability to provide the necessary radiation treatment at the time of surgery and is less disruptive and less burdensome on the patient's lifestyle. This is a great improvement in patient care at a lower cost."

The Xoft Axxent eBx System is U.S. Food and Drug Administration (FDA)-cleared for the treatment of early stage breast cancer, skin cancer and gynecological cancer. The Xoft System is designed to safely deliver radiation directly to cancer sites with minimal exposure to surrounding healthy tissue.

For more information: www.xoftinc.com/

Related Content

New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
IsoRay Funding Brain Cancer Treatment Research With Ochsner Clinic Foundation
News | Brachytherapy Systems | June 12, 2018
IsoRay Inc. announced the initiation of research funding for brain cancer treatment to Ochsner Clinic Foundation, a not...
News | Brachytherapy Systems | June 07, 2018
IsoRay Inc. announced the upcoming release of its Build-Blu delivery system for real-time prostate brachytherapy.
Raysearch RayStation
Feature | Radiation Therapy | June 05, 2018 | By Melinda Taschetta-Millane
Treatment planning systems are at the heart of r...
Beaumont Researchers Invent New Mode of Proton Treatment for Lung Cancer
News | Proton Therapy | May 31, 2018
Members of Beaumont Health’s proton therapy team presented research on a new treatment for patients with lung cancer at...
More Than 60 Percent of Patients Seeking Proton Therapy Initially Denied Coverage
News | Proton Therapy | May 25, 2018
The Alliance for Proton Therapy Access has released a national report revealing the heavy emotional and financial...
News | Treatment Planning | May 24, 2018
Daniela Schmitt, Ph.D., took top honors in the overall category of the 2018 TROG Plan Study: Stereotactic Radiosurgery...
Overlay Init